½ÃÀ庸°í¼­
»óǰÄÚµå
1599340

À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå : Á¦Ç°, ¼ö¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Vitrectomy Devices Market by Product (Illumination Devices, Photocoagulation Lasers, Vitrectomy Machines), Surgery (Anterior Vitreoretinal Surgery, Posterior Vitreoretinal Surgery), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 199 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀåÀº 2023³â 19¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2024³â¿¡´Â 22¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¬Æò±Õ 14.62% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 50¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â´Â ¸Á¸·¹Ú¸®, Ȳ¹Ý¿ø°ø, ´ç´¢¸Á¸·º´Áõ µî ´Ù¾çÇÑ ¾È°ú ÁúȯÀ» Ä¡·áÇÏ´Â ¼ö¼ú¿¡ »ç¿ëµÇ´Â Áß¿äÇÑ ÀåºñÀÔ´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â À¯¸®Ã¼ Àý»è±â, ÁÖÀÔ ÀåÄ¡¿Í °°Àº Àåºñ ÀÚü¿Í Á¶¸í ¹× °üÂû ½Ã½ºÅÛ°ú °°Àº °ü·Ã µµ±¸°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ÀåºñÀÇ Çʿ伺Àº ¾È°ú ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Àα¸ °í·ÉÈ­·Î ÀÎÇØ ÃÖ¼Òħ½À ¾È°ú ¼ö¼úÀÇ Á¤¹Ðµµ¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹ß»ýÇÕ´Ï´Ù. ÁÖ·Î º´¿ø, ¾È°ú Ŭ¸®´Ð ¹× ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASC)¿¡¼­ »ç¿ëµË´Ï´Ù. À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¼ö¼ú °á°ú °³¼±À¸·Î À̾îÁö´Â ±â¼ú Çõ½Å, ÀÇ·áºñ Áõ°¡, °í±Þ ¼ö¼ú ¿É¼Ç¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ÀÎ½Ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª ¼÷·ÃµÈ ¾È°ú ÀÇ»ç ºÎÁ·, ³ôÀº ¼ö¼ú ºñ¿ë, ÀáÀçÀûÀÎ ¼ö¼ú ÇÕº´Áõ µîÀÇ ¹®Á¦´Â ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. »õ·Î¿î ±âȸ¸¦ ¸ð»öÇϱâ À§ÇØ ½ÃÀå °³Ã´ ±â¾÷µéÀº º¸´Ù È¿À²ÀûÀÌ°í ºñ¿ë È¿À²ÀûÀÌ¸ç »ç¿ëÇϱ⠽¬¿î ±â±â °³¹ß¿¡ ÁýÁßÇϰí, Áõ°­Çö½Ç(AR)°ú ·Îº¿°øÇÐÀÇ ÅëÇÕÀ» ÅëÇØ Á¤È®¼º°ú Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÷´Ü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °³¹ßµµ»ó±¹À¸·ÎÀÇ ÁøÃâÀº À¯¸®ÇÑ ¼ºÀå °æ·Î¸¦ Á¦½ÃÇÕ´Ï´Ù. Çõ½ÅÀº ¶ÇÇÑ ¿Ü°ú ÀÇ»çÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ã۱â À§ÇØ ¼ö¼ú ±â±âÀÇ ÀÎü°øÇÐÀ» °³¼±ÇÏ°í ¼ö¼ú ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϱâ À§ÇÑ ±â±â ÅëÇÕÀ» Áß½ÉÀ¸·Î ÀÌ·ç¾îÁ®¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿ªÇÐÀÌ ÀÛ¿ëÇÏ´Â °¡¿îµ¥, Áö¼ÓÀûÀÎ ¿¬±¸ °³¹ßÀ» ¿ì¼±½ÃÇϰí, ±ÔÁ¦ Àå¾Ö¹°À» ÇØ°áÇϰí, Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ±¸ÃàÇÏ¿© ½ÃÀå ÀÔÁö¸¦ È®´ëÇÏ´Â ±â¾÷¿¡°Ô´Â ½ÃÀå °æÀïÀÌ °è¼ÓµÇ°í ÀÖÁö¸¸ À¯¸ÁÇÑ ½ÃÀåÀÔ´Ï´Ù. °á±¹ ÀÌ ½ÃÀåÀÇ ÇѰè¿Í ÀáÀç·ÂÀ» Á¾ÇÕÀûÀ¸·Î ÀÌÇØÇÏ´Â °ÍÀÌ À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ºÐ¾ßÀÇ ±âȸ¸¦ Ȱ¿ëÇϰí Áö¼ÓÀûÀÎ ¼ºÀåÀ» À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 19¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 22¾ï 2,200¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 50¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 14.62%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³

À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ë·ÉÀα¸ Áõ°¡¿Í ½Ã°¢Àå¾Ö ȯÀÚ Áõ°¡
    • ½Ã°¢Àå¾Ö¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̱â À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê
    • ¾È°ú ¼ö¼ú¿¡¼­ ÃÖ¼Òħ½ÀÀû ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • È¿°úÀûÀÎ ÇコÄÉ¾î ¼­ºñ½º ºÎÁ·°ú ÇコÄÉ¾î ±â¼ú º¸±Þ Áö¿¬
  • ½ÃÀå ±âȸ
    • À¯¸®Ã¼¸Á¸· ¼ö¼ú ±â±â¿¡ ´ëÇÑ È¹±âÀûÀÎ ¹ßÀü
    • ½ÅÈï ½ÃÀå ³» ÀÇ·á½Ã¼³ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ¸Á¸·À¯¸®Ã¼ ¼ö¼ú¿¡ µû¸¥ À§Ç輺

Porter's Five Forces : À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲÀÇ °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå¿¡¼­ÀÇ ¼º°øÀ» À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå : Á¦Ç°º°

  • Á¶¸í Àåºñ
  • ±¤ÀÀ°í ·¹ÀÌÀú
  • À¯¸®Ã¼ÀýÁ¦¼ú ±â°è
  • À¯¸®Ã¼ÀýÁ¦¼ú ÆÑ

Á¦7Àå À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå : ¼ö¼úº°

  • ÀüºÎ À¯¸®Ã¼¸Á¸· ¼ö¼ú
  • ÈĺΠÀ¯¸®Ã¼¸Á¸· ¼ö¼ú

Á¦8Àå À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå : ¿ëµµº°

  • ´ç´¢¸Á¸·º´Áõ
  • Ȳ¹Ý¿ø°ø
  • ¸Á¸·¹Ú¸®
  • À¯¸®Ã¼ ÃâÇ÷

Á¦9Àå À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø
  • ¾È°ú Ŭ¸®´Ð

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ À¯¸®Ã¼ ÀýÁ¦¼ú ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï »óȲ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Alcon Vision LLC
  • Bausch & Lomb Incorporated
  • BVI Medical, Inc.
  • Carl Zeiss Meditec AG
  • D.O.R.C. Dutch Ophthalmic Research Center(International) B.V.
  • Haag-Streit AG
  • Johnson & Johnson Vision Care, Inc.
  • Lab Medica Systems Pvt. Ltd.
  • MedOne Surgical, Inc.
  • NIDEK CO., LTD.
  • OCULUS Surgical, Inc.
  • Peregrine Surgical
  • Topcon Corporation
ksm 24.12.04

The Vitrectomy Devices Market was valued at USD 1.94 billion in 2023, expected to reach USD 2.22 billion in 2024, and is projected to grow at a CAGR of 14.62%, to USD 5.06 billion by 2030.

Vitrectomy devices are critical instruments used in surgical procedures to treat various eye conditions, including retinal detachment, macular holes, and diabetic retinopathy. The scope of this market encompasses the devices themselves-vitreous cutters, infusion devices, and others-along with associated tools such as illumination and viewing systems. The necessity of these devices arises from the increasing prevalence of ocular disorders and an aging population, which elevates the demand for precision in minimally invasive ophthalmic surgeries. They are primarily used in hospitals, ophthalmic clinics, and ambulatory surgery centers. Key growth factors influencing the vitrectomy devices market include technological innovations leading to enhanced surgical outcomes, rising healthcare expenditure, and increased awareness of advanced surgical options among patients. However, challenges such as a shortage of skilled ophthalmic surgeons, high procedural costs, and potential surgical complications may impede market growth. To tap into emerging opportunities, market players can focus on developing more efficient, cost-effective, and user-friendly devices, with attention to integrating augmented reality and robotics for improved precision and outcomes. Furthermore, expanding into developing regions where the demand for advanced medical treatments is rising presents a favorable growth avenue. Innovation should also center around enhancing the ergonomics of surgical tools for improved surgeon comfort and device integration to streamline surgical workflows. Amidst these dynamics, the market remains competitive but promising for companies that prioritize continuous research and development, address regulatory hurdles, and foster strategic partnerships to expand market presence. Ultimately, comprehensively understanding both the limitations and potential within this market is crucial for leveraging opportunities and sustaining growth in the vitrectomy devices sector.

KEY MARKET STATISTICS
Base Year [2023] USD 1.94 billion
Estimated Year [2024] USD 2.22 billion
Forecast Year [2030] USD 5.06 billion
CAGR (%) 14.62%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vitrectomy Devices Market

The Vitrectomy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in number of geriatric population coupled with growing cases of visual impairment
    • Government initiatives for increasing awareness related to visual impairment
    • Growing demand for minimally invasive techniques for eye surgery
  • Market Restraints
    • Lack of effective healthcare services and slow penetration of healthcare technology
  • Market Opportunities
    • Significant advancements related to vitreoretinal surgery devices
    • Increasing healthcare facilities in the emerging markets
  • Market Challenges
    • Risks associated with vitrectomy

Porter's Five Forces: A Strategic Tool for Navigating the Vitrectomy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vitrectomy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vitrectomy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vitrectomy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vitrectomy Devices Market

A detailed market share analysis in the Vitrectomy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vitrectomy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vitrectomy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vitrectomy Devices Market

A strategic analysis of the Vitrectomy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vitrectomy Devices Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC, Bausch & Lomb Incorporated, BVI Medical, Inc., Carl Zeiss Meditec AG, D.O.R.C. Dutch Ophthalmic Research Center (International) B.V., Haag-Streit AG, Johnson & Johnson Vision Care, Inc., Lab Medica Systems Pvt. Ltd., MedOne Surgical, Inc., NIDEK CO., LTD., OCULUS Surgical, Inc., Peregrine Surgical, and Topcon Corporation.

Market Segmentation & Coverage

This research report categorizes the Vitrectomy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Illumination Devices, Photocoagulation Lasers, Vitrectomy Machines, and Vitrectomy Packs.
  • Based on Surgery, market is studied across Anterior Vitreoretinal Surgery and Posterior Vitreoretinal Surgery.
  • Based on Application, market is studied across Diabetic Retinopathy, Macular Hole, Retinal Detachment, and Vitreous Hemorrhage.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Ophthalmology Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in number of geriatric population coupled with growing cases of visual impairment
      • 5.1.1.2. Government initiatives for increasing awareness related to visual impairment
      • 5.1.1.3. Growing demand for minimally invasive techniques for eye surgery
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of effective healthcare services and slow penetration of healthcare technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant advancements related to vitreoretinal surgery devices
      • 5.1.3.2. Increasing healthcare facilities in the emerging markets
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with vitrectomy
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vitrectomy Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Illumination Devices
  • 6.3. Photocoagulation Lasers
  • 6.4. Vitrectomy Machines
  • 6.5. Vitrectomy Packs

7. Vitrectomy Devices Market, by Surgery

  • 7.1. Introduction
  • 7.2. Anterior Vitreoretinal Surgery
  • 7.3. Posterior Vitreoretinal Surgery

8. Vitrectomy Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Diabetic Retinopathy
  • 8.3. Macular Hole
  • 8.4. Retinal Detachment
  • 8.5. Vitreous Hemorrhage

9. Vitrectomy Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals
  • 9.4. Ophthalmology Clinics

10. Americas Vitrectomy Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vitrectomy Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vitrectomy Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alcon Vision LLC
  • 2. Bausch & Lomb Incorporated
  • 3. BVI Medical, Inc.
  • 4. Carl Zeiss Meditec AG
  • 5. D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.
  • 6. Haag-Streit AG
  • 7. Johnson & Johnson Vision Care, Inc.
  • 8. Lab Medica Systems Pvt. Ltd.
  • 9. MedOne Surgical, Inc.
  • 10. NIDEK CO., LTD.
  • 11. OCULUS Surgical, Inc.
  • 12. Peregrine Surgical
  • 13. Topcon Corporation
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦